A Novel Approach of Targeted Immunotherapy against Adenocarcinoma Cells with Nanoparticles Modified by CD16 and MUC1 Aptamers

Figure 4

Morphological characterization of the amphipathic NP. (a and b) Confocal microscopic images showing the morphology of the amphipathic NP (a) and the unmodified NP (b). (c and d) DLS assay showing the size distributions of the amphipathic NP (c) and the unmodified NP (d).

(a)

(b)

(c)

(d)